Literature DB >> 11705115

Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener.

S D Glick1, I M Maisonneuve, K K Szumlinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11705115     DOI： 10.1016/s0099-9598(01)56006-x

Source DB:  PubMed          Journal:  Alkaloids Chem Biol        ISSN： 1099-4831


× No keyword cloud information.
  9 in total

Review 1.  Kappa opioids as potential treatments for stimulant dependence.

Authors:  Thomas E Prisinzano; Kevin Tidgewell; Wayne W Harding
Journal:  AAPS J       Date:  2005-10-19       Impact factor: 4.009

2.  The CHRNA5/A3/B4 gene cluster and tobacco, alcohol, cannabis, inhalants and other substance use initiation: replication and new findings using mixture analyses.

Authors:  Gitta H Lubke; Sarah H Stephens; Jeffrey M Lessem; John K Hewitt; Marissa A Ehringer
Journal:  Behav Genet       Date:  2012-03-01       Impact factor: 2.805

Review 3.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 4.  The anti-addiction drug ibogaine and the heart: a delicate relation.

Authors:  Xaver Koenig; Karlheinz Hilber
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

5.  Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation.

Authors:  Tamara Antonio; Steven R Childers; Richard B Rothman; Christina M Dersch; Christine King; Martin Kuehne; William G Bornmann; Amy J Eshleman; Aaron Janowsky; Eric R Simon; Maarten E A Reith; Kenneth Alper
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 6.  Ibogaine and addiction in the animal model, a systematic review and meta-analysis.

Authors:  M Belgers; M Leenaars; J R Homberg; M Ritskes-Hoitinga; A F A Schellekens; C R Hooijmans
Journal:  Transl Psychiatry       Date:  2016-05-31       Impact factor: 6.222

Review 7.  Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.

Authors:  Paul Cumming; Milan Scheidegger; Dario Dornbierer; Mikael Palner; Boris B Quednow; Chantal Martin-Soelch
Journal:  Molecules       Date:  2021-04-22       Impact factor: 4.411

8.  Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites.

Authors:  Margarida L F Martins; Paniz Heydari; Wenlong Li; Alejandra Martínez-Chávez; Nikkie Venekamp; Maria C Lebre; Luc Lucas; Jos H Beijnen; Alfred H Schinkel
Journal:  Front Pharmacol       Date:  2022-03-04       Impact factor: 5.810

9.  Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile.

Authors:  Xaver Koenig; Michael Kovar; Lena Rubi; Agnes K Mike; Peter Lukacs; Vaibhavkumar S Gawali; Hannes Todt; Karlheinz Hilber; Walter Sandtner
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-22       Impact factor: 4.219
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.